Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults



Status:Completed
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:11/18/2012
Start Date:January 2010
End Date:May 2013

Use our guide to learn which trials are right for you!

Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy


Oral human papillomavirus (HPV) and oral warts are common health concerns for HIV-infected
people. This study will examine the frequency of oral HPV DNA shedding and oral warts in
HIV-infected people who are enrolled in ACTG A5257 and who are beginning treatment with
highly active antiretroviral therapy (HAART).


Oral HPV infection occurs at a higher rate among HIV-infected people than among the general
population. Recent research in the United States and Europe has also found that HIV-infected
people have a higher risk of oral and oropharyngeal squamous cell cancer than HIV-uninfected
people. In one study, it was found that HPV seropositivity was associated with an increased
risk of squamous cell carcinoma of the oropharynx (SCCOP). In addition to SCCOP, another
HPV-related health concern is oral warts, a condition for which there is no effective
treatment. Even after beginning treatment with highly active antiretroviral therapy (HAART),
active HPV replication in the mouth and oropharynx may persist in HIV-infected people,
leading to an increased risk of SCCOP and oral warts. The purpose of this study is to
evaluate the frequency of oral HPV DNA shedding and oral warts in HIV-infected people prior
to HAART initiation and at regular time points after HAART initiation.

ACTG A5257 is a study that is comparing the effectiveness of three non-nucleoside reverse
transcriptase inhibitor (NNRTI)-sparing HAART regimens in treatment-naïve participants. This
study will enroll participants from the ACTG A5257 study. Participants will attend a
baseline study visit at the same time as their ACTG A5257 baseline study visit. At baseline
and at Week 4, 16, 24, and 48 study visits, participants will undergo an examination of
their mouth, throat wash and saliva collection, and behavioral questionnaires. A blood
collection will also occur at Week 24.

Inclusion Criteria:

- Meet inclusion criteria for and be enrolled in ACTG A5257

- Ability and willingness of participant or legal guardian/representative to provide
informed consent

Exclusion Criteria:

- Co-enrollment in A5260s

- Has begun receiving HAART as part of the A5257 study

- Has ever received an HPV vaccine or plans to receive an HPV vaccine in the 6 months
after study entry
We found this trial at
34
sites
New York, New York 10032
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Stanford, California 94304
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Atlanta, Georgia 30308
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Baltimore, Maryland 21201
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Birmingham, Alabama 35294
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
317
mi
from 43215
Boston, MD
Click here to add this to my saved trials
Boston, Massachusetts 02114
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Camden, New Jersey 08103
418
mi
from 43215
Camden, NJ
Click here to add this to my saved trials
Chapel Hill, North Carolina 27514
354
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Chicago, Illinois 60612
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60611
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio 45267
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Cleveland, Ohio 44109
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Cleveland, Ohio 44106
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
1
mi
from 43215
Colombus, OH
Click here to add this to my saved trials
Detroit, Michigan 48202
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Durham, North Carolina 27710
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Greensboro, North Carolina 27401
321
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Los Angeles, California 90095
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90033
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Miami, Florida 33139
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Nashville, Tennessee 37204
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
New York, New York 10011
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Providence, Rhode Island 02906
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Rochester, New York 14642
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Rochester, New York 14607
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
San Diego, California 92103
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Seattle, Washington 98104
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
St. Louis, Missouri 63110
394
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials